New York, New York-- (Newsfile Corp. - December 1, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Symbotic Inc. (NASDAQ: SYM) for potential violations ...

Today, Benzinga's options scanner spotted 25 options trades for Teva Pharmaceutical Indus. This is not a typical pattern. The sentiment among these major traders is split, with 24% bullish and 60% ...

BFA Law Alerts TD Bank Investors that a Class Action Lawsuit was Filed Against the Company for Fraud and Urges You to Contact the Firm ...

Daiwa Securities Group Inc. lifted its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 10.0% ...

Valued at $29.1 billion by market cap, California-based Deckers Outdoor Corporation (DECK) stands tall as a global powerhouse ...

Teva's reasonable valuation, an improving pipeline, and sales and profit growth potential are good enough reasons for those ...

Generic and biosimilar drugs are often preferred over the brand name version due to their cheaper prices. Generics are exact ...

EW STOCK REPORT: Suffer Losses On Your Edwards Lifesciences Investment? Contact BFA Law About The Pending Class Action Lawsuit (NYSE:EW) ...

As a result of the news, Elanco's stock price declined over 21%, from $17.97 per share on June 26, 2024 to $14.27 per share on June 27, 2024. BFA Law is investigating whether Elanco and certain of its ...

MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced ...

The management anticipates stronger performance in the coming quarters due to the company's upcoming new launches, the onset ...

GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new drug for Sanfillippo syndrome type A ...